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Abstract: Mitochondrial biogenesis is an essential process for cell viability. Mice with disruption of the growth hormone
receptor (GHR) gene (Ghr gene) in the liver (LiGHRKO), in contrast to long‐lived mice with global deletion of the Ghr gene
(GHRKO), are characterized by lack of improved insulin sensitivity and severe hepatic steatosis. Tissue‐specific disruption
of the GHR in liver results in a mouse model with dramatically altered GH/IGF1 axis. We have previously shown increased
levels of key regulators of mitochondrial biogenesis in insulin‐sensitive GHRKO mice. The aim of the present study is to
assess, using real‐time PCR, the gene expression of key regulators of mitochondrial biogenesis (Pgc1α, Ampk, Sirt1, Nrf2
and Mfn2) and a marker of mitochondrial activity (CoxIV) in brains, kidneys and livers of male and female LiGHRKO and
wild‐type (WT) mice. There were significant differences between males and females. In the brain, expression of Pgc1α,
Ampk, Sirt1, Nrf2 and Mfn2 was lower in pooled females compared to pooled males. In the kidneys, expression of Ampk
and Sirt1 was also lower in female mice. In the liver, no differences between males and females were observed. Sexual
dimorphism may play an important role in regulating the biogenesis of mitochondria.
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Insulin-like growth factor 1 (IGF1) mediates many of
GH’s physiological effects. IGF1 is primarily produced
in the liver and acts systemically, although other tissues
also may produce IGF1 where it may act locally (e.g.,
[19]). Therefore, suppression of GH signaling
selectively in different tissues emerges as a very
promising experimental approach to better understand
the mechanisms involved in regulating the effects of the
GH/IGF1 axis, and presumably in lifespan extension.
Thus, mice with tissue-specific ablation of the Ghr gene
recently have been generated [20-25], including mice
with tissue-specific deletion of GHR (and disruption of
GH signaling) in the liver (LiGHRKO). LiGHRKO
mice have decreased body fat, severely reduced levels
of circulating IGF1 and concurrently higher GH plasma
levels [20, 25]. It is of particular interest that LiGHRKO
mice show an absence of improved insulin sensitivity
and severe hepatic steatosis [20, 25], which is in
contrast to mice with global deletion of GHR. Both
sexes of LiGHRKOs are characterized by elevated
fasting blood glucose, while fasting insulin is higher
only in males. Moreover, males have normal glucose
tolerance and mild insulin resistance, while females are
glucose intolerant and insulin resistant [25].

INTRODUCTION
The biogenesis of mitochondria is a process by which
new mitochondria are formed and is critical for cell
viability [1]. Mitochondria are complex eukaryotic
organelles that play a crucial role in energy homeostasis
and metabolism. Disruption of mitochondrial biogenesis
may lead, via impaired oxidative stress resistance and
maintenance of energy production, to the development
of numerous degenerative and metabolic diseases [2, 3].
On the contrary, increased level of mitochondrial
biogenesis may prevent aging [4].
There are numerous key regulators of mitochondrial
biogenesis, including peroxisome proliferator-activated
receptor gamma (PPARγ) co-activator 1 alpha (PGC1α),
AMP-activated protein kinase (AMPK), sirtuin 1
(SIRT1), nuclear respiratory factor 2 (NRF2) and
mitofusin 2 (MFN2). Additionally, cytochrome c oxidase
(COX) is one of the mitochondrial activity markers.
PGC1α is the master regulator of mitochondrial
biogenesis. This transcriptional coactivator coordinates
the actions of several transcription factors and thereby
controls mitochondrial biogenesis (reviewed by [3]).
AMPK plays an important role as a cellular energy
sensor and is activated by an increase in intracellular
adenosine monophosphate (AMP)/adenosine triphosphate (ATP) ratio [5]. Sirtuin 1, sometimes referred to as a
nutrient deprivation sensor, belongs to the sirtuin
(NAD+–dependent deacetylases) family and stimulates
mitochondrial biogenesis via PGC1α deacetylation [3].
NRF2 is a nuclear-encoded transcription factor that binds
and activates various mitochondrial genes required for
electron transport and oxidative phosphorylation
[6]. MFN2 plays an essential role in mitochondrial fusion
and maintenance of the mitochondrial network
architecture [7, 8], which is essential for mitochondrial
activity and biogenesis.

A significant alterations in the weights of different organs
(e.g., brain, kidneys and liver) between control and
LiGHRKO mice were previously described [20, 25],
suggesting potential differences in apoptosis as well as in
mitochondrial function regulation, because mitochondria
are known to play an important role in regulation of the
process of apoptosis. Importantly, our recent studies
demonstrated a sex-dependent expression of apoptosisrelated genes in the brain and kidneys of LiGHRKO mice
without any significant main effects of sex in the liver
[26]. Additionally, analysis of expression of the
examined genes in the brains is related to the reported
preservation of cognitive function in aging GHRKO mice
[10]. For all these reasons, we decided to assess the effect
of liver-specific Ghr gene disruption on gene expression
of key regulators of mitochondrial biogenesis (Pgc1α,
Ampk, Sirt1, Nrf2, Mfn2) and a marker of mitochondrial
activity (CoxIV) in brains, kidneys and livers of males
and females 22-month old LiGHRKO mice compared to
males and females wild-type animals.

Long-lived mice with targeted global disruption of the
growth hormone (GH) receptor (GHR) gene (Ghr gene)
(GHRKO; GHR knockout; Laron dwarfs; Ghr-/-) [9] are
dwarf, obese and insulin sensitive [10]. We have
previously shown increased expression of key regulators
of mitochondrial biogenesis, including PGC1α, AMPK,
SIRT1, eNOS and MFN2 in the kidneys and heart of
GHRKO mice [11-13]. Moreover, GHRKO mice have
decreased levels of pro-apoptotic factors [13-16] and
decreased thyroid follicle size [17] with mild thyroid
hypofunction. Interestingly, preservation of cognitive
function in aging GHRKO mice was also observed [10].
Results obtained in these and in GH-deficient mice
suggest an essential role of GH-induced intracellular
signaling in lifespan regulation [18].
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We decided to use old mice for the following reasons.
First of all, in our paper published recently [26], we
have reported the sex dependence of the expression of
apoptosis-related genes in 22-month old LiGHRKO
mice. On the contrary, we did not find any differences
in apoptotic factors gene expression in younger 9month-old mice (unpublished data).Thus, knowing the
above-mentioned important role of mitochondria in the
apoptosis regulation, we decided to analyze the gene
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expression of the mitochondrial biogenesis-related
factors in 22-month old LiGHRKO mice.

respectively) (Figures 1A-E), demonstrating a significant
sex effect. CoxIV showed a tendency for lower gene
expression in female brains (p=0.055) (Figure 1F).
Moreover, Ampk and Nrf2 expression was lower in brains
of WT-females compared to WT-males (p=0.007 and
p=0.024 respectively, with genotype*sex interactions
reaching borderline statistical significance – p=0.054 and
p=0.053, respectively) (Figures 1B and 1D). There was a
weak and not statistically significant tendency for expression levels of all examined genes to be greater in female
LiGHRKO mice than in WT-females (Figures 1A-F).

RESULTS
Gene expression of key regulators of mitochondrial
biogenesis in the brain
In the brain, gene expression of Pgc1α, Ampk, Sirt1, Nrf2
and Mfn2 was lower in pooled females than in pooled
males (p=0.022, p=0.004, p=0.021, p=0.021, p=0.022,

Figure 1. Brain gene expression of key regulators of mitochondrial biogenesis. Brain mRNA expression of Pgc1α (A),
Ampk (B), Sirt1 (C), Nrf2 (D), Mfn2 (E) and CoxIV (F) in male and female of wild‐type (WT) and liver‐specific growth hormone
receptor knockout (LiGHRKO) mice. Each group consists of 7 animals. The data from real‐time PCR were normalized by the
housekeeping gene β2‐microglobulin (B2M) and shown as a relative expression. Values are means ± SEM. a, b – values that do
not share the same letter in the superscript are statistically significant (p<0.05). * – p<0.05 vs. male mice (the significance for
sex). There are the following significant p values: Pgc1α: 0.022, Ampk: 0.004, Sirt1: 0.021, Nrf2: 0.021, Mfn2: 0.022.
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Figure 2. Renal gene expression of key regulators of mitochondrial biogenesis. Kidney mRNA expression of
Pgc1α (A), Ampk (B), Sirt1 (C), Nrf2 (D) and CoxIV (E) in male and female of wild‐type (WT) and liver‐specific growth
hormone receptor knockout (LiGHRKO) mice. Each group consists of 7 animals. The data from real‐time PCR were
normalized by the housekeeping gene β2‐microglobulin (B2M) and shown as a relative expression. Values are means
± SEM. a, b – values that do not share the same letter in the superscript are statistically significant (p<0.05). * –
p<0.05 vs. male mice (the significance for sex). There are the following significant p values: Ampk: 0.041, Sirt1: 0.003.

Gene expression of key regulators of mitochondrial
biogenesis in the kidneys

Sirt1) in female compared to male mice was detected
(a significant sex effect; p=0.041, p=0.003,
respectively) (Figures 2B-C). Moreover, renal Sirt1
gene expression was lower in WT-females than in
WT-males (p=0.003) (Figure 2C). On the contrary,

In the kidneys, a decrease in gene expression of two
key regulators of mitochondrial biogenesis (Ampk and
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there were no differences in the expression of Pgc1α,
Nrf2 and CoxIV between male and female kidneys
(p=0.366, p=0.315, p=0.242) (Figures 2A, 2D and
2E). Similarly to the results obtained in the brain,

there appeared to be a weak tendency for increased
gene expression levels of the examined factors in
female LiGHRKO mice as compared with WTfemales (Figures 2A-E).

Figure 3. Hepatic gene expression of key regulators of mitochondrial biogenesis. Liver mRNA
expression of Pgc1α (A), Ampk (B), Sirt1 (C), Nrf2 (D), Mfn2 (E) and CoxIV (F) in male and female
of wild‐type (WT) and liver‐specific growth hormone receptor knockout (LiGHRKO) mice. Each
group consists of 7 animals. The data from real‐time PCR were normalized by the housekeeping
gene β2‐microglobulin (B2M) and shown as a relative expression. Values are means ± SEM. a –
values that share the same letter in the superscript are not statistically significant.
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controls, whereas nonagenarian parents had the lowest
content of mtDNA [28].Thus, mtDNA has been shown
to be negatively associated with familial longevity. The
content of mtDNA may be considered a marker for the
cellular amount of mitochondria and reflects the balance
between mitochondrial biogenesis and removal of
damaged mitochondria. Results of the study performed
by Passtoors et al. [29] have demonstrated that familial
longevity is also associated with reduced expression of
genes involved in the mTOR pathway. It is known that
this signaling pathway positively regulates genes
involved in mitochondrial biogenesis, e.g., PGC1α [3].
Therefore, one could hypothesize that unaltered levels
of key regulators of mitochondrial biogenesis in
LiGHRKO mice, as seen in the present study, do not
need to be considered a detrimental feature of these
mutant mice. Observations by Malik and Czajka [30]
showing opposite (decreased or increased) alterations in
mtDNA content in numerous diseases, including those
related to age (e.g., cancer or diabetes) also may support
this hypothesis. Clearly, further work is required to fully
elucidate the role of mitochondrial biogenesis regulation
in the lifespan extension.

Gene expression of key regulators of mitochondrial
biogenesis in the liver
Intriguingly, in the liver, neither sex nor genotype
significantly affected mRNA levels of the examined
factors (Pgc1α, Ampk, Sirt1, Nrf2, Mfn2 and CoxIV; for
sex – p=0.448, p=0.383, p=0.790, p=0.979, p=0.739,
p=0.283, respectively and for genotype – p=0.335,
p=0.677, p=0.921, p=0.371, p=0.215, p=0.938,
respectively) (Figures 3A-F).

DISCUSSION
Previous studies have shown increased levels of key
regulators of mitochondrial biogenesis in mice with
global GHR knockout [11, 12]. This increase was
interpreted as a potentially beneficial characteristic of
long-lived mice with global GHR deletion [13].
Therefore, one could envision that similar changes
would be detected in the liver of mice with the same
genetic intervention limited to the hepatic tissue
(LiGHRKO). Surprisingly, deletion of the GHR only in
the liver did not lead to any differences in gene
expression of key regulators of mitochondrial
biogenesis in this organ compared to wild-type mice.
Thus, a main significant genotype effect has not been
found. In two organs in which Ghr gene was not
deleted, namely in brains and kidneys, there were also
no significant effects of the genotype. These results may
appear counterintuitive in the context of findings in
global GHRKO mice, although it is known that
LiGHRKO mice, in contrast to GHRKO animals, do not
share the same phenotype in many aspects [20, 25], and
have no change in lifespan (do not live longer) [27].
Furthermore, one should emphasize that our recent
studies on the expression of apoptosis-related genes in
LiGHRKO mice have also revealed an absence of
genotype effect [26]. Apparently, effects of global GHR
deletion differ from the effects of liver-specific GHR
knockout. The observed differences strongly emphasize
the necessity of further studies on the GH signaling
regulation to elucidate which mechanisms involved in
this process may play the most crucial role and why the
disruption of the GHR in one tissue or organ may have
completely opposite effects compared to global GHR
deletion.

As noted above, direction of changes in levels of key
regulators of mitochondrial biogenesis in LiGHRKO
mice differs from those previously demonstrated in
GHRKO mutants. Moreover, observations in mice with
tissue-specific deletion of the GHR (not only limited to
the liver) point to different characteristics of these
mutants compared to global GHRKO animals. For
example, there is a lack of glucose homeostasis
improvement in fat-specific GHRKO (FaGHRKO) mice
[24]. Moreover, in contrast to global GHRKOs, mice
with GHR deletion in muscles (MuGHRKO) are
characterized by insulin resistance and glucose
intolerance [21]. GHR disruption in pancreatic betacells can lead to impaired insulin secretion [22].
Therefore, one could hypothesize that global GHR
disruption with its numerous beneficial effects, but not
tissue-specific knockout of Ghr gene, may play a
crucial role in lifespan extension and resistance to the
development of cancer and diabetes seen in GHRKO
dwarfs [18].
In the present study, a clear difference between sexes (a
main significant sex effect) was demonstrated. Namely,
our findings have shown that gene expression of key
regulators of mitochondrial biogenesis was lower in
females compared to male mice. Importantly, the results
of recently published studies seem to support a
hypothesis suggesting a potential role of sexual
dimorphism in the regulation of biogenesis of
mitochondria and may confirm the decreased intensity
of this important process in females compared to males.

Besides global GHRKO mice, the levels of key
regulators of mitochondrial biogenesis have not yet
been assessed in other long-lived mouse strains.
However, there are studies on mitochondrial content
and biogenesis in human subjects from the Leiden
Longevity Study [28]. The authors have shown that the
offspring of nonagenarians had lower mitochondrial
DNA (mtDNA) content compared to age-matched
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Sex-dependence of mitochondrial biogenesis was
observed by Drake et al. [31] in their studies on proteins
involved in mTOR signaling pathway. Furthermore,
Straface et al. [32] hypothesize that differences between
sexes may result from differences at the cellular level.
Differences between males and females also have been
reported by Sharma et al. [33], who demonstrated the
lower gene expression of Pgc1α in female cerebellar
granule neurons (CGNs) than in male mice, resembling
our findings in the brain. In contrast, gene expression of
Pgc1α did not change in the other organs examined in the
present study, namely in the kidneys and liver. These
findings seem to be quite difficult to explain. However,
van Leeuwen et al. [28] reported lack of association
between PGC1α gene expression and mtDNA content.
Moreover, similarly to our current results showing a
decrease of Nrf2 and Mfn2 mRNA level, gene
expressions of related factors – Nrf1 and Mfn1 in CGNs –
were also decreased in females compared to males,
although Mfn2 mRNA remained unchanged [33]. In
Wistar rats, mtDNA content was lower in female brown
adipose tissue than in the same tissue of males [34] and
had a tendency to be decreased in female liver, although
without statistically significant difference [35].

alterations in serum leptin and circulating interleukin 6
levels as well as increased total lean body mass are
present in female but not in male FaGHRKO mice. In
GHRKO dwarfs, significant sex differences in the
percent fat mass and in absolute lean mass have been
reported [39]. These differences between male and
female mice may be related to sex differences in GH
secretion pattern and pituitary GH network responses
[40]. Plasma GH pattern in males is characterized by
high GH pulses occurring with a specific periodicity; in
females, GH secretion is less variable with smaller GH
pulses and higher interpulse levels [41].
In summary, the role of GH signaling in the regulation
of mitochondrial biogenesis appears to be much more
complicated than once thought. Local deletion of the
GHR in the liver may serve as a very useful
experimental animal model for analyzing the role of
tissue-specific disruption of GH signaling in the control
of processes observed in living organisms. Importantly,
sexual dimorphism may play a relevant role in the
regulation of mitochondrial biogenesis under conditions
of reduced GH signaling. Further studies are required to
elucidate the relationships between GH-induced
signaling, sex and mitochondria.

Intriguingly, in other studies, opposite results, i.e.,
increased level of mitochondrial biogenesis or function
in the female sex, was detected. For example, in the
Leiden Longevity Study, women had a higher mtDNA
content than men [28]. Increased biogenesis of
mitochondria may result from female sex hormones
administration. Capllonch-Amer et al. [36] reported that
17β-estradiol (E2) up-regulated the markers of
mitochondrial biogenesis, dynamics and function in the
skeletal muscles in rats. E2 also induced stimulation
of mitochondrial biogenesis in white adipocytes in vitro
[37]. Moreover, there is a wealth of evidence that
demonstrates 17β-E2 increases lipid oxidation or
improves metabolic parameters (reviewed by [38]).
Therefore, one could hypothesize that females may be
more efficient in substrate utilization even though they
have reduced mitochondrial biogenesis. Females may
have more functional reserve so a diminishment of
mitochondrial biogenesis or activity may not translate
into metabolic perturbations.

MATERIALS AND METHODS
Animals. LiGHRKO mice were generated at Ohio
University as previously described [25]. Briefly, mice
carrying the GHR “floxed” allele were crossed with
B6.Cg-Tg(alb-cre)21Mgn/J transgenic mice purchased
from Jackson Laboratories (Bar Harbor, ME USA) [24,
25]. Brains, kidneys and livers from approximately 22month-old male and female wild-type (WT) and liverspecific GHRKO (LiGHRKO) mice were provided
from Mayo Clinic, Rochester, MN. The animals
comprised four (4) experimental groups: wild-type
males (WT-male), liver-specific GHR knockout males
(LiGHRKO-male), wild-type females (WT-female) and
liver-specific GHR knockout females (LiGHRKOfemale), each group consisting of 7 animals.
RNA extraction and complementary DNA (cDNA)
transcription. RNA was extracted from the homogenates
of the examined tissues using a miRNeasy Mini Kit
(Qiagen, USA) in accordance with the manufacturer’s
instruction. RNA quantity and quality were analyzed
using a NanoDrop 1000 Spectrophotometer (Thermo
Scientific, USA). Reverse transcription was performed,
and complementary DNA was synthesized using an
iScript cDNA Synthesis Kit (Bio-Rad Laboratories,
Hercules, CA, USA) according to the manufacturer’s
instruction.

One should emphasize that there are clear sex
differences in various characteristics of mice with local
disruption of the GHR or with global GHR knockout.
For example, increased local Igf1 gene expression in
subcutaneous and retroperitoneal white adipose tissue
and decreased levels of circulating insulin-like growth
factor-binding protein-5 (IGFBP-5) and IGFBP-7 in
female LiGHRKO mice compared to controls have been
reported [25]. Moreover, List et al. [24] report that
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genes of interest compared to the control group. For
RT-PCR, the primers used are listed in Table 1.

Real-time polymerase chain reaction (RT-PCR). Realtime polymerase chain reaction (RT-PCR) was carried
out using the StepOne™ Real-Time PCR System
instrument (Life Technologies, USA) with iQ SYBR
Green Supermix (Bio-Rad Laboratories, Hercules, CA,
USA). The three steps of the PCR included:
denaturation at 94°C for 2 minutes, annealing at 62°C
for 30 seconds with fluorescence reading, and
extension at 72°C for 30 seconds. In addition, a
melting curve was done for each reaction to evaluate
the potential of nonspecific products. β2-microglobulin
(B2M), which was previously validated in our
laboratory as the most appropriate gene for
normalizing the data [12, 13, 42], was used as a
housekeeping gene. Gene expression was assessed by
measuring steady state levels of mRNA. Relative
expression from RT-PCR was calculated using the
equation 2A-B/2C-D (where A = Cycle Threshold [Ct]
number for the gene of interest in the first control
sample; B = Ct number for the gene of interest in the
analyzed sample; C = Ct number for the housekeeping
gene in the first control sample; D = Ct number for
housekeeping gene in the analyzed sample). The first
control was expressed as 1.00 by this equation, and all
other samples were calculated in relation to this value.
Then, the results in the control group (WT-males)
were averaged. All other outputs were divided by the
mean value of the relative expression in the control
group to yield the fold change of the expression of

Statistical analysis. The data are expressed as mean ±
SEM. To evaluate the main effects of the genotype and
sex, we used two-way analysis of variance (ANOVA).
For analyzing differences between group means, we
used a Bonferroni post-hoc test. A value of p<0.05 was
considered significant. All statistical calculations were
conducted using SPSS version 17.0 (SPSS, Chicago, IL)
with α=0.05. All graphs were created using Prism 4.02
(GraphPad Software, San Diego, CA).
To statistically analyze differences between males and
females (a potential significant gender effect) we
pooled all males (WT-male and LiGHRKO-male mice)
and all females (WT-female and LiGHRKO-female
mice) (see the Results section). Such statistical
analysis may allow detect some potentially significant
differences, which couldn’t been found when analysis
between particular experimental groups was only
performed. We would like also to emphasize that the
employed method (pooling samples from male and
female mice) is fully justified and statistically correct
because the groups that were being combined (pooled)
[i.e., WT-males and LiGHRKO-males (pooled into
male group) vs. WT-females and LiGHRKO-females
(pooled into female group)] were not significantly
different from each other.

Table 1. Primers used for gene expression analyses.
Gene

GenBank accession no.

Forward (5’-3’)

Reverse (5’-3’)

β2-microglobulin

NM_009735

aagtatactcacgccaccca

aagaccagtccttgctgaag

Pgc1α

BC066868

tacgcaggtcgaacgaaact

acttgctcttggtggaagca

Ampk

AF036535

cacttgtctgcatctctcca

cttgaggaacttgaggatcc

Sirt1

AY377984

gtaatgtgaggagtcagcac

ttggacattaccacgtctgc

Nrf2

U20532

tcagtgactcggaaatggag

ttcacgcataggagcactgt

Mfn2

NM_133201

ccacaaagtgagtgaacgtc

atccaccagaaagctggtgc

CoxIV

NM_009941

acagcccttggcttgatgta

tggcctgaaagcttccacta
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